NITI Aayog launch Guidelines for Public Private Partnership for Non Communicable Diseases

  • Posted on: 23 October 2018
  • By: Shalini.Sharma

Pharma Admission

Pharma courses

pharma admission

pharma courses

 

NITI Aayog launched the Guidelines and Model Concessionaire Agreement, MCA for Public Private Partnership, PPP for Non Communicable Diseases. The documents have been designed to supplement efforts for provision of prevention and treatment services of non-communicable diseases related to Cardiac Sciences, Oncology, and Pulmonary Sciences at the district hospitals especially in tier 2 & 3 cities.

The documents have been developed by NITI Aayog in partnership with the Ministry of Health and Family Welfare, State Governments and representatives from the healthcare industry. Member NITI Aayog, Dr.VKPaulalong with partner agencies involved in preparation of the two documents were present on this occasion.

PPP Units to be established in District Hospitals. Model covers prevention and treatment of 3 Non-Communicable Diseases viz. Cardio Vascular diseases, Cancers and Pulmonary diseases. All these services in PPP facility to be offered by a Single partner or a single consortium of private partners.  Private partner to invest in upgrading/building and equipping the facility and responsible for operational management and service delivery.

The guidelines comes in the backdrop of the fact that the contribution of non-communicable diseases (NCD) to the overall disease burden in the country has increased over the years. In the past many district hospitals in the country have focused mainly on communicable diseases and reproductive and child health. As a result of which the capacity for handling NCD cases has not been adequately developed.

Health and wellness component of Ayushman Bharat will address the requirements of preventive and promotive health services through Health & Wellness Centres. Despite the best intent to promote wellness and deliver a broad range of services through these Centres, some cases will require hospitalized treatment and will spill over to district hospitals.

Presently, in India patients have to travel long distances for availing medical services for NCDs due to urban bias in the availability of private health care, especially secondary and tertiary care which is disproportionately skewed towards Tier-1 cities. The patients in mofussil towns and rural areas are largely underserviced. In this context, PPP for NCDs in district hospitals will play a pivotal role in ensuring the availability of the services at least at the district headquarters.

The Model Concessionaire Agreement and the guidelines co-locating private players for the Non Communicable Diseases - Cardiac, Oncology, and Pulmonary diseases at district hospital covers the rationale, roles and responsibilities, partnership structure, governance and management structure etc. These PPP guidelines and MCA target the critical gaps that can be filled by ‘strategic purchasing’ in public health services highlighted in the National Health Policy 2017.  This would play a key role in directing private investment towards those areas and those services for which currently there are no providers or few providers.

The MCA and Guidelines for the provision of prevention and treatment services for NCDs could be adapted and customized by each State to ultimately develop appropriate strategies in accordance with the requirements provided in these documents. This will make it easier for the State to use these templates and modify them appropriately to invite bidders.

<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email


 

Latest News